NJ-2021-002

N/A

Report date: 2024/05/27 17:07:02
NME

Base Information

Drug NameNJ-2021-002
Drug Alias NameNJ-2021-002NJ-2021-002(Z)NJ-2021-002(F)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHemorrhoidsProctitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhoidsProctitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A